(Q36240014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612069%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

review article

1 reference

title

Type II diabetes and syndrome X. Pathogenesis and glycemic management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612069%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Type II Diabetes and Syndrome X: Pathogenesis and Glycemic Management (English)

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30220-2

15 October 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30220-2

15 October 2022

author name string

J. H. Karam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1612069

15 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1612069

15 October 2022

publication date

1 June 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612069%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.elsevier.com/content/article/PII:S0889852918302202?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30220-2

https://api.elsevier.com/content/article/PII:S0889852918302202?httpAccept=text/plain

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30220-2

Endocrinology and Metabolism Clinics of North America

15 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612069%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612069%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

329-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612069%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612069%20AND%20SRC:MED&resulttype=core&format=json

Diabetes mellitus and exercise

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Metformin revisited: its actions and indications for use.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Lilly lecture 1990. Molecular defects in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Sulfonylurea receptors, ion channels, and fruit flies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

The potentiation of exogenous insulin by tolbutamide in depancreatized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Clinical review 26: Insulin resistance in obese and nonobese man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Acute effects of insulin on cardiovascular function and noradrenaline uptake and release

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Efficacy of glyburide in diabetics poorly controlled on first-generation oral hypoglycemics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

The effect of insulin on renal sodium metabolism. A review with clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Lesions of the Pancreatic Islets Produced in Cats by Administration of Glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Acute actions of sulfonylurea drugs during long-term treatment of NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Glucagon and growth hormone secretion in insulin-treated diabetics: Effects of added sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Treatment of NIDDM with insulin agonists or substitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Secretion of somatostatin from the normal and diabetic pancreas. Studies in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Beta Cell Secretion—from the Standpoint of a Pathobiologist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Effect of Conventional and Intensified Insulin Therapy on Free-Insulin Profiles and Glycemic Control in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Evidence for an association of high blood pressure and hyperinsulinemia in obese man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Clinical pharmacology of sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Sulfonylureas. Why, which, and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Insulin resistance--mechanisms, syndromes, and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

1 reference

7 January 2021

Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

A two-step model for development of non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Racial differences in the relation between blood pressure and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Intraislet negative insulin-glucagon feedback

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Characterization and significance of sulfonylurea receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Mechanism of improvement in glucose metabolism after chronic glyburide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Effect of insulin on renal sodium handling in hyperinsulinaemic type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Insulin and atheroma. 20-yr perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Serum-insulin in essential hypertension and in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Kelly West Lecture 1991. Challenges in diabetes epidemiology--from West to the rest

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2818%2930220-2

7 January 2021

Sulfonylurea signal transduction

8

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30220-2

Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in non-insulin-dependent diabetes, high blood pressure, dyslipidemia and coronary heart disease

15 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30220-2

Endocrine and metabolic effects of experimental obesity in man

15 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(18)30220-2

15 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612069%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference